MedPath
NMPA Approval

Telmisartan and Amlodipine Tablets (Ⅱ)

国药准字H20213466

June 8, 2021

Drug Information

替米沙坦氨氯地平片(Ⅱ)

片剂

每片含替米沙坦40mg与苯磺酸氨氯地平5mg(按氨氯地平计)

化学药品

June 8, 2021

Company Information

Applicant Company

四川省眉山市青神县青城镇机械大道13号附2号

Manufacturing Company

眉山经济开发区新区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

替米沙坦氨氯地平片(Ⅱ) - NMPA 批准文号 | MedPath